-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F/Rn1m5kPGdRNAufnfxqzC5ZEpiyI3T5+5k6FMBKdMT5WIii8D6kbqV6jjbAhDNg d1MlQWh9ysF5zHf55lz++g== 0000071241-03-000022.txt : 20031117 0000071241-03-000022.hdr.sgml : 20031117 20031117155439 ACCESSION NUMBER: 0000071241-03-000022 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20031117 ITEM INFORMATION: Acquisition or disposition of assets FILED AS OF DATE: 20031117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEW BRUNSWICK SCIENTIFIC CO INC CENTRAL INDEX KEY: 0000071241 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY APPARATUS & FURNITURE [3821] IRS NUMBER: 221630072 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-06994 FILM NUMBER: 031008095 BUSINESS ADDRESS: STREET 1: 44 TALMADGE RD STREET 2: PO BOX 4005 CITY: EDISON STATE: NJ ZIP: 08818-4005 BUSINESS PHONE: 9082871200 MAIL ADDRESS: STREET 1: 44 TALMADGE ROAD STREET 2: PO BOX 4005 CITY: EDISON STATE: NJ ZIP: 08818-4005 8-K/A 1 doc1.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 NOVEMBER 17, 2003 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) NEW BRUNSWICK SCIENTIFIC CO., INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) NEW JERSEY 0-6994 22-1630072 (STATE OR OTHER JURISDICTION OF (COMMISSION FILE NUMBER) (IRS EMPLOYER IDENTIFICATION NO.) INCORPORATION) 44 TALMADGE ROAD, EDISON, NJ 08818-4005 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE) REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (732) 287-1200 (FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT) ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS. THE FOLLOWING INFORMATION IS FURNISHED PURSUANT TO ITEM 2 "ACQUISITION OR DISPOSITION OF ASSETS": ON NOVEMBER 17, 2003, NEW BRUNSWICK SCIENTIFIC CO., INC. ISSUED A PRESS RELEASE REPORTING ITS ACQUISITION OF RS BIOTECH LTD. THE PRESS RELEASE IS ATTACHED HERETO AS EXHIBIT 99.1. EXHIBIT DESCRIPTION 99.1 PRESS RELEASE ISSUED NOVEMBER 17, 2003 SIGNATURES PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAD DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED HEREUNTO DULY AUTHORIZED. NEW BRUNSWICK SCIENTIFIC CO., INC. DATE: NOVEMBER 17, 2003 BY: /S/SAMUEL EICHENBAUM SAMUEL EICHENBAUM VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER EX-99.1 3 doc2.txt PRESS RELEASE ISSUED NOVEMBER 17, 2003 NEWS RELEASE - ------------- NEW BRUNSWICK SCIENTIFIC CO., INC. BOX 4005 - 44 TALMADGE RD. - EDISON, NJ 08818-4005 - 732-287-1200 FAX 732-287-4222 INTERNET: HTTP://WWW.NBSC.COM - E-MAIL: BIOINFO@NBSC.COM INVESTOR CONTACT: Samuel Eichenbaum Vice President, Finance 732.650.2500 E-mail: same@nbsc.com FOR IMMEDIATE RELEASE --------------------- NEW BRUNSWICK SCIENTIFIC CO., INC. ACQUIRES RS BIOTECH LABORATORY EQUIPMENT LIMITED EDISON, NEW JERSEY, NOVEMBER 17, 2003-New Brunswick Scientific Co., Inc. (NASDAQ: NBSC), today announced it has acquired RS Biotech Laboratory Equipment Ltd., a designer and manufacturer of CO2 incubators. Founded in 1991 and based in Irvine, Scotland, RS Biotech's line of state-of-the-art incubators are sold in more than 40 countries and have been utilized in numerous studies conducted by life science and biotech research customers. The company's annual sales approximate $3 million and the acquisition will be immediately accretive to New Brunswick Scientific's earnings. Although the terms of the acquisition were not disclosed the purchase price consisted of cash and notes. Malcolm McNab, Managing Director and one of the founders of RS Biotech, said: "RS Biotech's impressive range of Galaxy CO2 Incubators adds strength and fits naturally into the New Brunswick Scientific product portfolio. There is obvious synergy across a wide range of activities, and considerable advantage to be gained from complementary strengths ultimately leading to benefits for all our customers and associated parties." David Freedman, Chairman and Chief Executive Officer of New Brunswick Scientific, stated: "We are very pleased to have acquired RS Biotech, as its Galaxy CO2 Incubators represent a strong addition to our lines of biological shakers, ultra-low temperature freezers, fermentors and cell culture equipment. Furthermore, from a human resources point of view, the quality and talent of their people matches well with our dedicated and experienced staff." New Brunswick Scientific Co., Inc. designs and manufactures a wide variety of research equipment and scientific instruments for the life sciences and holds a minority equity position in Antyra Inc., a drug-lead-discovery operation. This press release includes statements that may constitute forward-looking statements made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. This information may involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Further information concerning risk factors is described in the Company's Securities and Exchange Commission filings. -- -----END PRIVACY-ENHANCED MESSAGE-----